Lokken Investment Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Lokken Investment Group's PFE Position: Q3 2025 in Review
Lokken Investment Group reduced its Pfizer (PFE) stake by 0.58% in Q3 2025, selling an estimated $2.71K and leaving 18,969 shares worth $483K. The position accounts for 0.17% of the portfolio, ranked #92.
Lokken Investment Group first reported a position in PFE in Q4 2020 and has held it in 20 quarters since. The position peaked at $1.68M in Q4 2021. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- Lokken Investment Group held 18,969 shares of Pfizer worth $483K as of Q3 2025.
- Lokken Investment Group sold 110 Pfizer shares in Q3 2025, an estimated $2.71K.
- Pfizer made up 0.17% of Lokken Investment Group's portfolio in Q3 2025, its #92 holding.
- Lokken Investment Group first reported a position in Pfizer in Q4 2020 and has held it in 20 quarters since.
- Lokken Investment Group's Pfizer position peaked at $1.68M in Q4 2021.
- 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on Lokken Investment Group's 13F filing for Q3 2025, filed 5 Nov 2025.